New Jersey Headlines

Europe Blood Screening Market is Estimated to Value $1.17 Billion by 2025: Grand View Research, Inc.

 Breaking News
  • No posts were found

Europe Blood Screening Market is Estimated to Value $1.17 Billion by 2025: Grand View Research, Inc.

May 16
13:05 2019
Europe Blood Screening Market is Estimated to Value $1.17 Billion by 2025: Grand View Research, Inc.

Grand View Research, Inc. – Market Research And Consulting.
According to report published by Grand View Research, The Europe Blood Screening Market size was valued at USD 648.5 million in 2017. Rising number of blood transfusion procedures is expected to be the major factor boosting the market growth.

According to a report, Europe Blood Screening Market Size, Share & Trends Analysis Report By Technology (NAT, ELISA, CLIA, NGS, Western Blotting), By Product (Reagents, Instruments), And Segment Forecasts, 2018 – 2025, published by Grand View Research, Inc., The Europe blood screening market size is expected to reach USD 1.17 billion by 2025 according to a new report by Grand View Research, Inc. The market is expected to record a CAGR of 7.7% during the forecast period. Increasing number of blood transfusion processes performed along with stringent regulations in Europe mandating screening tests, such as NAT for testing HIV, HBV, and HCV, is contributing to the market growth. 

Key Takeaways from the report: 

  • NAT led the technology segment in 2017 owing to a regulatory obligation for mandatory NAT screening for all blood donations.
  • On the basis of product, reagents led the Europe blood screening market in 2017
  • Germany held a majority of the market share in 2017 due to large number of blood donors.
  • Moreover, stringent regulations in the country for screening of donations also contributed to its growth. The Paul-Ehrlich-Institut, a medical regulatory body in Germany, mandates NAT testing for HCV and HIV for all blood donations.
  • Roche Diagnostics; Bio-Rad Laboratories, Inc.; Siemens Healthcare GmbH; Grifols, S.A.; Becton, Dickinson and Company; Agilent Technologies; Thermo Fisher Scientific, Inc.; and Danaher Corp. are some of the key companies operating in this market.

Browse More Reports in Medical Devices Industry:

Structural Heart Devices Market: The large prevalence of target disease is the key driver of the structural heart devices market. Almost 60 million people in the U.S. have structural defects in their hearts.

Pen Needles Market: The global pen needles market size was valued at USD 1.5 billion in 2015 and is anticipated to exhibit attractive growth over the forecast period.

 U.K. blood screening market size, by product, 2014 - 2025 (USD Million)

Moreover, growth in the overall number of complex surgeries that require a large amount of blood and blood products along with rising cases of road accidents is expected to drive the market further. Additionally, import of products through contract agreements and development in the product technology by manufacturers of blood screening reagents and instruments are contributing to market expansion in the region.

For example, DiaSystem Scandinavia AB signed a distribution agreement with SNIBE, an Asian immunology test producer that focuses on immunoassay analyzers based on CLIA technology. DiaSystem specializes in the production and supply of reagents used in chemistry and immunoturbidimetry. This agreement has provided the former company with automated chemiluminescence instrument delivering a complete analytical system in areas, such as thyroid, renal function, hepatitis, and hepatic fibrosis.

Grand View Research has segmented the Europe blood screening market on the basis of technology, product, and country:

Europe Blood Screening Technology Outlook (Revenue, USD Million, 2014 – 2025)

  • Nucleic Acid Amplification Test (NAT)
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Chemiluminescence Immunoassay (CLIA)
  • Next Generation Sequencing (NGS)
  • Western Blotting

Europe Blood Screening Product Outlook (Revenue, USD Million, 2014 – 2025)

  • Reagents
  • Instruments

Europe Blood Screening Country Outlook (Revenue, USD Million, 2014 – 2025)

  • U.K.
  • Germany
  • France
  • Italy
  • Spain

Explore the BI enabled intuitive market research database, Navigate with Grand View Compass, by Grand View Research, Inc.

About Grand View Research

Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.

For more information: www.grandviewresearch.com

Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:201, Spear Street, 1100
City: San Francisco
State: California
Country: United States
Website: www.grandviewresearch.com/industry-analysis/europe-blood-screening-market

Categories